Skip to main content
logo
VISEN Pharmaceuticals (HKG:2561)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.93
-0.07 (-0.50%)
Oct 30, 2026, 3:59 PM HKT

VISEN Pharmaceuticals Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,5223,445---
Market Cap Growth
-63.78%----
Enterprise Value
1,1432,563---
Last Close Price
13.9332.80---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
38.7222761.01---
PB Ratio
1.964.06---
P/TBV Ratio
1.974.07---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
29.0616934.54---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.260.230.010.010.01
Net Debt / Equity Ratio
-0.49-0.60-0.83-0.88-0.95
Net Debt / EBITDA Ratio
1.481.901.162.501.74
Net Debt / FCF Ratio
0.721.011.431.272.50
Asset Turnover
0.0400.01--
Quick Ratio
2.553.003.946.797.19
Current Ratio
4.004.474.267.228.15
Return on Equity (ROE)
-31.37%-50.52%-57.66%-47.83%-
Return on Assets (ROA)
-15.62%-23.58%-29.52%-14.69%-
Return on Capital Employed (ROCE)
-33.00%-31.30%-72.10%-35.50%-54.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-18.34%-8.19%---
FCF Yield
-34.88%-14.51%---
Buyback Yield / Dilution
-11.78%-10.71%---